Edwards Lifesciences’ Aortic Valve Conduit Approved for Bio-Bentall Procedures
The FDA has approved Edwards Lifesciences’ “ready-to-implant” Konect aortic valve conduit for use in bio-Bentall procedures.
Bio-Bentall procedures are complex cardiac surgeries that involve the replacement of the aortic valve, aortic root and ascending aorta. They are done to treat disease of the aortic valve and ascending aorta.
The Konect device features technology that helps to improve the aortic valve’s durability.